首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 基因療法

市場調查報告書

商品編碼

2148367

腺結合病毒（AAV）載體生產市場：按載體類型、生產方法、應用、最終用戶和地區分類。

Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type, By Production Method, By Application, By End User, By Geography

出版日期: 2026年09月07日 | 出版商:

Coherent Market Insights | 英文 250 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

腺結合病毒（AAV）載體生產市場預計在2026年達到31.8億美元，預計2033年將達到71.1億美元。預計從2026年到2033年，其複合年成長率將達到12.2%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	31.8億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	12.20%	2033年市場規模預測：	71.1億美元

腺結合病毒（AAV）載體的生產是現代基因治療的關鍵環節，它提供了一種非致病性病毒遞送平台，用於攜帶治療性遺傳物質，應用於罕見疾病、遺傳性視網膜疾病、血友病和中樞神經系統疾病的治療。該市場涵蓋了上游工程（如質體DNA和轉染系統）以及下游製程（如純化、填充和包裝以及品管）。

隨著基因療法從臨床開發走向商業性應用，對可擴展、高產量、經濟高效且可重複的腺相關病毒（AAV）生產流程的需求日益成長。生物製藥公司、合約研發生產機構（CDMO）和研究機構正在投資最先進的生產技術，以應對產量和可擴展性方面的挑戰，而不斷變化的監管環境也在推動基於AAV的療法的開發和商業化。

市場動態

全球腺結合病毒（AAV）載體生產市場的發展動力源於基因治療產品線的不斷擴展、AAV療法應用的日益普及以及對病毒載體生產基礎設施投資的不斷成長。生產技術的進步，例如基於桿狀病毒的系統、改進的生物反應器和最佳化的上游工程，正幫助製造商提高產量並擴大生產規模。

然而，腺結合病毒（AAV）載體生產市場的成長受到許多因素的限制，例如高昂的生產成本、複雜的生產流程、有限的產能以及嚴格的品質要求。儘管如此，下一代衣殼工程、合成生物學、人工智慧驅動的製程最佳化以及高度專業化的AAV合約研發生產機構（CDMO）的擴張，都蘊藏著巨大的發展機會。新興市場對基因治療研發投入的增加，預計將進一步推動AAV生產生態系統的發展。

本次調查的主要特點

本研究揭示了各個細分市場的潛在商機，並為該市場說明了一個具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
本研究根據以下參數，對全球腺結合病毒(AAV) 載體製造市場的主要公司進行了概況介紹：公司概況、產品系列、主要亮點、財務績效和策略。
本報告提供的見解將使企業行銷負責人和經營團隊能夠就未來的產品發布、產品類型升級、市場擴張和行銷策略做出明智的決策。
這份「全球腺結合病毒（AAV）載體製造市場」報告針對產業內的各種相關人員，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用分析全球腺結合病毒(AAV) 載體製造市場中使用的各種策略矩陣來簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

F. Hoffmann-La Roche Ltd
Charles River Laboratories International, Inc.
Oxford Biomedica plc
WuXi AppTec Co., Ltd.
YposKesi
Sarepta Therapeutics, Inc.
Pfizer Inc.
Genezen
Creative Biogene
GenScript Biotech Corporation

第10章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI10059

Adeno Associated Virus (AAV) Vector Manufacturing Market is estimated to be valued at USD 3.18 Bn in 2026 and is expected to reach USD 7.11 Bn by 2033, growing at a compound annual growth rate (CAGR) of 12.2% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 3.18 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	12.20%	2033 Value Projection:	USD 7.11 Bn

Adeno-Associated Virus (AAV) vector manufacturing is an important element of modern gene therapy, providing a non-pathogenic viral delivery platform for therapeutic genetic material for applications such as rare diseases, inherited retinal disorders, hemophilia and central nervous system conditions. The market encompasses the end-to-end manufacturing ecosystem including upstream processing, plasmid DNA and transfection systems, downstream purification, fill-finish and quality control.

As gene therapy transitions from clinical development to commercial application, the need for scalable, high-yield, cost-effective, and reproducible AAV manufacturing processes is growing. Biopharmaceutical companies, CDMOs, and research institutions are investing in cutting-edge production technologies to address yield and scalability challenges, while changing regulatory landscapes are enabling the development and commercialization of AAV-based therapies.

Market Dynamics

The global adeno associated virus (AAV) vector manufacturing market is driven by the growing gene therapy pipeline, increasing adoption of AAV based therapeutics and rising investments in viral vector manufacturing infrastructure. New developments in production technologies such as baculovirus-based systems, improved bioreactors and optimized upstream processing are enabling manufacturers to improve yields and scale up their operations.

However, the growth of adeno associated virus (AAV) vector manufacturing market is limited by factors such as high production costs, complex manufacturing processes, limited capacity, and stringent quality requirements. Nevertheless, significant opportunities exist in next-generation capsid engineering, synthetic biology, AI-driven process optimization and expansion of specialty AAV CDMOs. Growing investments in gene therapy development across emerging markets are further expected to support expansion of the AAV manufacturing ecosystem.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global adeno associated virus (AAV) vector manufacturing market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include F. Hoffmann-La Roche Ltd, Charles River Laboratories International, Inc., Oxford Biomedica plc, WuXi AppTec Co., Ltd., YposKesi, Sarepta Therapeutics, Inc., Pfizer Inc., Genezen, Creative Biogene, and GenScript Biotech Corporation
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global adeno associated virus (AAV) vector manufacturing market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global adeno associated virus (AAV) vector manufacturing market

Market Segmentation

Vector Type Insights (Revenue, USD Bn, 2021 - 2033)
- Single-Stranded AAV (ssAAV)
- Self-Complementary AAV (scAAV)
Production Method Insights (Revenue, USD Bn, 2021 - 2033)
- Transient Transfection
- Baculovirus-Based Production
- Stable Cell Line
- Others
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Gene Therapy
- Cell Therapy
- Vaccine Development
- Research Applications
- Others
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Pharmaceutical and Biotechnology Companies
- Contract Development and Manufacturing Organizations (CDMOs)
- Academic and Research Institutions
- Others
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- F. Hoffmann-La Roche Ltd
- Charles River Laboratories International, Inc.
- Oxford Biomedica plc
- WuXi AppTec Co., Ltd.
- YposKesi
- Sarepta Therapeutics, Inc.
- Pfizer Inc.
- Genezen
- Creative Biogene
- GenScript Biotech Corporation

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Production Method
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Application
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By End User
- Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Industry Trends

4. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Vector Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Single-Stranded AAV (ssAAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Self-Complementary AAV (scAAV)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Production Method, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Transient Transfection
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Baculovirus-Based Production
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Stable Cell Line
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Gene Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Cell Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Vaccine Development
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Pharmaceutical and Biotechnology Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Contract Development and Manufacturing Organizations (CDMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Adeno Associated Virus (AAV) Vector Manufacturing Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Vector Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Production Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User,2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

F. Hoffmann-La Roche Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Charles River Laboratories International, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Oxford Biomedica plc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
WuXi AppTec Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
YposKesi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sarepta Therapeutics, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Genezen
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Creative Biogene
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
GenScript Biotech Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies